SEARCH

SEARCH BY CITATION

References

  • 1
    Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 5466.
  • 2
    Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99103.
  • 3
    Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 92938.
  • 4
    Czaja AJ. Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 1999; 57: 4968.
  • 5
    Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002; 357: 713.
  • 6
    Czaja AJ, Bianchi FB, Carpenter HA, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005; 41: 20715.
  • 7
    Johnson P, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 95863.
  • 8
    Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006; 43: 5328.
  • 9
    Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005; 42: 5362.
  • 10
    Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 6969.
  • 11
    Newton JL, Burt AD, Park JB, Matthew J, Bassendine MF, James OFW. Autoimmune hepatitis in older patients. Age Ageing 1997; 26: 4414.
  • 12
    Parker DR, Kingham JGC. Type I autoimmune hepatitis is primarily a disease of later life. Q J Med 1997; 90: 28996.
  • 13
    Schramm C, Kanzler S, Zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001; 96: 158791.
    Direct Link:
  • 14
    Boelsterli UA. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf 2002; 25: 63348.
  • 15
    Conforti A, Leone R, Ghiotto E, et al. Spontaneous reporting of drug-related hepatic reactions from two Italian regions (Lombardy and Veneto). Dig Liver Dis 2000; 32: 1623.
  • 16
    Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001; 48: 97102.
  • 17
    Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006; 101: 55660.
    Direct Link:
  • 18
    Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002; 97: 31605.
    Direct Link:
  • 19
    Samuel D, Riordan S, Strasser S, Kurtovic J, Singh-Grewel I, Koorey D. Severe autoimmune hepatitis first presenting in early post partum period. Clin Gastroenterol Hepatol 2004; 2: 6224.
  • 20
    Omagari K, Kinoshita H, Kato Y, et al. Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 1999; 34: 2216.
  • 21
    Kanzler S, Lohr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol 2001; 39: 33941.
  • 22
    Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type I autoimmune hepatitis. Gastroenterology 1996; 110: 84857.